| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 6,197,198 | 111,860,000 | 49.84% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 3,052,130 | 48,834,000 | 21.76% | ||
| 3 | IGNYTA INC COM | 3,972,800 | 21,533,000 | 9.59% | ||
| 4 | Opko Health, Inc. | 14,000,000 | 19,753,000 | 8.80% | PRN | |
| 5 | BIOMARIN | 90,215 | 7,019,000 | 3.13% | ||
| 6 | ALIBABA GROUP HLDG LTD | 60,000 | 4,772,000 | 2.13% | ||
| 7 | MERRIMACK PHARMACEUTI | 3,500,000 | 3,965,000 | 1.77% | PRN | |
| 8 | NEKTAR THERAPEUTICS COM | 260,000 | 3,700,000 | 1.65% | ||
| 9 | BIOCRYST PHARMACEUTICALS | 430,000 | 1,221,000 | 0.54% | ||
| 10 | LIPOCINE INC NEW | 260,000 | 790,000 | 0.35% | ||
| 11 | Life Technologies Corp | 279,425 | 777,000 | 0.35% | ||
| 12 | CELLDEX THERAPEUTICS INC NEW | 50,000 | 220,000 | 0.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-013257, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
